Rituximab for the treatment of type II mixed cryoglobulinemia [1] (multiple letters)

Arthritis and Rheumatism

Volumn 46, Issue 8, 2002, Pages 2252-2254

  Zaja, Francesco ^a   De Vita, Salvatore ^a   Russo, Domenico ^a   Michelutti, Angela ^a   Fanin, Renato ^a   Ferraccioli, Gianfranco ^a   Baccarani, Michele ^b   Langford, Carol A ^c  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD19 ANTIGEN; CD20 ANTIGEN; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; DANAZOL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISONE; RHEUMATOID FACTOR; RITUXIMAB;

ADULT; AGED; ANTIBODY TITER; ARTERY THROMBOSIS; BLINDNESS; CASE REPORT; CLINICAL FEATURE; CRYOGLOBULINEMIA; DRUG EFFICACY; FEMALE; HUMAN; LETTER; LYMPHOCYTE PROLIFERATION; MALE; MIXED CRYOGLOBULINEMIA TYPE 2; PANNICULITIS; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036675113     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10345     Document Type: Letter

References (0)